These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10756981)

  • 1. Female breast carcinomas: nuclear and cytoplasmic proteins versus steroid receptors.
    Bryś M; Romanowicz-Makowska H; Nawrocka A; Krajewska WM
    Cytobios; 2000; 101(397):87-94. PubMed ID: 10756981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of periostin in human breast cancer.
    Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
    J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
    Townsend PA; Dublin E; Hart IR; Kao RH; Hanby AM; Cutress RI; Poulsom R; Ryder K; Barnes DM; Packham G
    J Pathol; 2002 May; 197(1):51-9. PubMed ID: 12081204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
    Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
    Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific polypeptide differences in normal versus malignant breast tissue by two-dimensional electrophoresis.
    Wirth PJ
    Electrophoresis; 1989; 10(8-9):543-54. PubMed ID: 2806203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
    Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
    Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
    Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
    Jin R; Bay BH; Chow VT; Tan PH; Lin VC
    Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
    J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BigH3 protein expression as a marker for breast cancer.
    Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
    Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
    Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of aromatase promoter activity in human breast tissue by nuclear receptors.
    Yang C; Yu B; Zhou D; Chen S
    Oncogene; 2002 Apr; 21(18):2854-63. PubMed ID: 11973645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.